HIGHLIGHTS
- who: Alba Agudo-López from the Laboratory of Translational Oncology, Instituto de Investigación Sanitaria Hospital , de Octubre (i +, ), Avda de Córdoba S/N, Madrid, Spain have published the research work: Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin, in the Journal: (JOURNAL)
- what: The authors aimed to compare the cytotoxic effects of cisplatin and a trans-sulfonamide-platinum-complex (TSPC) in two human melanoma cell lines that differ in their TP53 status: SK-MEL-5 TP53 wild type and SK-MEL . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.